Literature DB >> 9482586

Sequences of the ribonucleotide reductase-encoding genes of felid herpesvirus 1 and molecular phylogenetic analysis.

K Willoughby1, M Bennett, R A Williams, C McCracken, R M Gaskell.   

Abstract

The felid herpesvirus 1 (FHV-1) genes encoding the two ribonucleotide reductase (RR) subunits (RR1, large subunit and RR2, small subunit) were cloned and their nucleotide (nt) sequence determined. The RR1 open reading frame (ORF) is 2358 nts long and is predicted to encode a protein of 786 amino acids (aa). In common with herpesviruses in the Varicellovirus genus of the alphaherpesvirus subfamily, FHV-1 RR1 lacks the N-terminal serine threonine protein kinase region present in herpes simplex virus (HSV)-1 and -2. FHV-1 RR1 has a predicted aa identity of 47-64% with other alphaherpesvirus RR1 peptides, falling to 26-29% for gammaherpesviruses. The RR2 ORF is 996 nts long, predicted to encode a protein of 332 aa and has aa identities of 64-70% with alphaherpesviruses and 38-39% with gammaherpesviruses. Molecular phylogenetic analysis groups FHV-1 with equid herpesviruses 1 and 4 (EHV 1 and 4), pseudorabies virus (PRV) and bovid herpesvirus 1 (BHV 1) within the genus Varicellovirus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9482586     DOI: 10.1023/a:1007924419113

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  65 in total

1.  Herpes simplex virus type 1 ribonucleotide reductase null mutants induce lesions in guinea pigs.

Authors:  S R Turk; N A Kik; G M Birch; D J Chiego; C Shipman
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

Review 2.  Ribonucleotide reductases.

Authors:  J Stubbe
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1990

3.  The unique N-terminal domain of the large subunit of herpes simplex virus ribonucleotide reductase is preferentially sensitive to proteolysis.

Authors:  H Lankinen; E Telford; D MacDonald; H Marsden
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

Review 4.  Interactions between deoxyribonucleotide and DNA synthesis.

Authors:  P Reichard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

5.  Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale.

Authors:  D J McGeoch; S Cook
Journal:  J Mol Biol       Date:  1994-04-22       Impact factor: 5.469

6.  Ribonucleotide reductase--a radical enzyme.

Authors:  P Reichard; A Ehrenberg
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

7.  The herpes simplex virus type 1 ribonucleotide reductase is a tight complex of the type alpha 2 beta 2 composed of 40K and 140K proteins, of which the latter shows multiple forms due to proteolysis.

Authors:  R Ingemarson; H Lankinen
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

8.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

9.  Primary structure of the herpesvirus saimiri genome.

Authors:  J C Albrecht; J Nicholas; D Biller; K R Cameron; B Biesinger; C Newman; S Wittmann; M A Craxton; H Coleman; B Fleckenstein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.

Authors:  A D Idowu; E B Fraser-Smith; K L Poffenberger; R C Herman
Journal:  Antiviral Res       Date:  1992-02       Impact factor: 5.970

View more
  2 in total

1.  Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.

Authors:  Y Sun; J Conner
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles.

Authors:  D N Everly; G S Read
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.